RE: Desensitization Protocol

[Guest guest]

I will be out of the office 09/04/06-9/07/06 returning 09/08/06. Please call

315 464-5413 with any urgent concerns while I am away.

Have a nice day!

Donovan

Transplant Finacial Coordinator

[Guest guest]

Rituximab 100MG code 99.10 J9310 Josie Transplant Financial Specialist The Methodist Hospital Ph# Fax# From: TxFinancialCoordinators [mailto:TxFinancialCoordinators ] On Behalf Of Louis Sent: Wednesday, September 06, 2006 2:00 PMTo: TxFinancialCoordinators Subject: Desensitization ProtocolHello TFC'sNeed another Code for Out-Patient Rituximab, present Code 996.81 is not enough for the infusion center.Thanks, Louis.Methodist. Leading Medicine. Named by FORTUNE magazine's "100 Best Companies to Work For" in2006Named by U.S. News World Report as one of "America's BestHospitals"Designated as a Magnet hospital for excellence in nursing ***CONFIDENTIALITY NOTICE*** This e-mail is the property of The Methodist Hospital and/or itsrelevant affiliates and may contain confidential and privilegedmaterial for the sole use of the intended recipient(s). Any review,use, distribution or disclosure by others is strictly prohibited.If you are not the intended recipient (or authorized to receive forthe recipient), please contact the sender and delete all copies ofthe message. Thank you.

[Guest guest]

Try J9310

Desensitization Protocol

Hello TFC's

Need another Code for Out-Patient Rituximab, present Code 996.81 is not

enough for the infusion center.

Thanks, Louis.

[Guest guest]

These are the current diagnosis codes that reflect all coverage and approved changes (LCD 06-038) as of 08/15/2006 for Rituximab.

Note: If the purpose of the service is an encounter for antineoplastic immunotherapy, V58.12, providers should also identify the ICD-9-CM code for the malignancy.

200.00 - 200.88

LYMPHOSARCOMA AND RETICULOSARCOMA

202.00 - 202.08

OTHER MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE

202.40 - 202.48

LEUKEMIC RETICULOENDOTHELIOSIS

202.80 - 202.88

OTHER LYMPHOMAS

202.90 - 202.98

OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE

204.10 - 204.11

LYMPHOID LEUKEMIA

238.7

NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER LYMPHATIC AND HEMATOPOIETIC TISSUES

273.3

MACROGLOBULINEMIA

287.30 - 287.39

PRIMARY THROMBOCYTOPENIA, UNSPECIFIED

714.0-714.2

RHEUMATOID ARTHRITIS

714.4

CHRONIC POST RHEUMATIC ARTHROPATHY

795.79

OTHER AND UNSPECIFIED NONSPECIFIC IMMUNOLOGICAL FINDINGS

996.80 - 996.89

COMPLICATIONS OF TRANSPLANTED ORGANS

V49.83

AWAITING ORGAN TRANSPLANT STATUS

V58.12

ENCOUNTER FOR IMMUNOTHERAPY FOR NEOPLASTIC CONDITION

-----Original Message-----From: Louis Sent: Wednesday, September 06, 2006 12:00 PMTo: TxFinancialCoordinators Subject: Desensitization Protocol

Hello TFC'sNeed another Code for Out-Patient Rituximab, present Code 996.81 is not enough for the infusion center.Thanks, Louis.

The contents of this electronic mail message and any attachments

are confidential, possibly privileged and intended for the

addressee(s) only. Only the addressee(s) may read, disseminate,

retain or otherwise use this message. If received in error, please

immediately inform the sender and then delete this message without

disclosing its contents to anyone.

[Guest guest]

Thanks a Bunch.

At 04:33 PM 9/6/2006, you wrote:

>Try J9310

>

> Desensitization Protocol

>

>

>Hello TFC's

>

>Need another Code for Out-Patient Rituximab, present Code 996.81 is not

>enough for the infusion center.

>

>Thanks, Louis.

>

>

>

>

>

[Guest guest]

Lori THANKS, Louis.

At 04:47 PM 9/6/2006, you wrote:

These

are the current diagnosis codes that reflect all coverage and approved

changes (LCD 06-038) as of 08/15/2006 for Rituximab.

Note: If the purpose of the service is

an encounter for antineoplastic immunotherapy, V58.12, providers should

also identify the ICD-9-CM code for the malignancy.

200.00 - 200.88

LYMPHOSARCOMA AND RETICULOSARCOMA

202.00 - 202.08

OTHER MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE

202.40 - 202.48

LEUKEMIC RETICULOENDOTHELIOSIS

202.80 - 202.88

OTHER LYMPHOMAS

202.90 - 202.98

OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC

TISSUE

204.10 - 204.11

LYMPHOID LEUKEMIA

238.7

NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER LYMPHATIC AND HEMATOPOIETIC

TISSUES

273.3

MACROGLOBULINEMIA

287.30 - 287.39

PRIMARY THROMBOCYTOPENIA, UNSPECIFIED

714.0-714.2 RHEUMATOID ARTHRITIS

714.4 CHRONIC POST RHEUMATIC ARTHROPATHY

795.79 OTHER AND UNSPECIFIED NONSPECIFIC IMMUNOLOGICAL FINDINGS

996.80 - 996.89

COMPLICATIONS OF TRANSPLANTED ORGANS

V49.83

AWAITING ORGAN TRANSPLANT STATUS

V58.12

ENCOUNTER FOR IMMUNOTHERAPY FOR NEOPLASTIC CONDITION

Desensitization

Protocol

Hello TFC's

Need another Code for Out-Patient Rituximab, present Code 996.81 is

not

enough for the infusion center.

Thanks, Louis.

The contents of this electronic mail message and any attachments

are confidential, possibly privileged and intended for the

addressee(s) only. Only the addressee(s) may read, disseminate,

retain or otherwise use this message. If received in error, please

immediately inform the sender and then delete this message without

disclosing its contents to anyone.